PFM Health Sciences
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- Health Tech
- Biotechnologynology
About
PFM Health Sciences is a distinguished healthcare investment advisor located in San Francisco, established in 2004. Under the leadership of Founding Partner and Chief Investment Officer Brian Grossman, the firm focuses on forging strategic partnerships with cutting-edge companies in the biopharmaceutical, medical technology, life sciences, and healthcare sectors. PFM Health Sciences leverages deep industry knowledge and a robust network to identify and support innovative solutions that advance patient care and drive sustainable growth within the healthcare ecosystem. Through a disciplined investment approach, the firm aims to deliver exceptional value to its clients while contributing to the advancement of healthcare technologies and therapies.
PFM Health Sciences is a distinguished healthcare investment advisor located in San Francisco, established in 2004. Under the leadership of Founding Partner and Chief Investment Officer Brian Grossman, the firm focuses on forging strategic partnerships with cutting-edge companies in the biopharmaceutical, medical technology, life sciences, and healthcare sectors. PFM Health Sciences leverages deep industry knowledge and a robust network to identify and support innovative solutions that advance patient care and drive sustainable growth within the healthcare ecosystem. Through a disciplined investment approach, the firm aims to deliver exceptional value to its clients while contributing to the advancement of healthcare technologies and therapies.
Investment Thesis
PFM Health Sciences believes in partnering with innovative biopharma, medical technology, life science, and healthcare service companies. The firm focuses on secular healthcare innovation, specialist bottomup approaches, sustainability, risk management, and flexibility in investments. PFM leverages its expertise in public market investing to effectively identify and invest in innovative, highgrowth, and disruptive private healthcare companies. In the public markets, their strategy includes a subsector specialist approach and active risk management to create attractive riskadjusted returns.